Application and evaluation of Syndrome differentiation Xerox in chronic disease management of patients with advanced lung cancer

Phase 1

Recruiting

• Conditions: ung cancer

• Registration Number: ITMCTR2100004467
• Lead Sponsor: Dongfang Hospital of Beijing University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Patients aged 45-80 years old;
2. Patients meeting the diagnostic criteria of advanced lung cancer;
3. Patients who met the diagnostic criteria of anxiety state;
4. Patients meeting the diagnostic criteria of sleep disorders;
5. Subjects with informed consent signed the informed consent.

Exclusion Criteria

1. Patients with serious primary diseases or complications such as heart, liver, lung, kidney, etc;
2. Patients whose expected survival time is less than 6 months;
3. Patients who cannot cooperate with music therapy;
4. Patients who participated in any clinical trial within 30 days before screening;
5. Patients with any concomitant diseases that may interfere with the trial procedure or evaluation, or other conditions considered unsuitable by the researchers.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SAS;KPS;PSQI;CEA;